Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 16Inflammatory Breast Neoplasms 4Stomach Neoplasms 3Neutropenia 1Melanoma 1Lymphoma 1Hodgkin Disease 1Gastro Oesophageal Cancer 1Esophageal Neoplasms 1

Interventions

Filgrastim 4Etoposide 3Cytarabine 2Carboplatin 2pegfilgrastim 1liposomal amphotericin B 1Vincristine 1Thrombopoietin 1Thioguanine 1Taxes 1Radiotherapy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Moxifloxacin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Leucovorin 1Ifosfamide 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Epirubicin 1Doxorubicin 1Docetaxel 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neutropenia × Epirubicin × Clear all
NCT00002866 2020-04-01

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1 Completed
50 enrolled
Breast

Breast Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡